Artificial intelligence at the time of COVID-19: who does the lion's share?

Davide NegriniElisa DaneseBrandon M HenryGian Luca SalvagnoMartina Montagnana

Published in: Clinical chemistry and laboratory medicine (2022)

The lion's share of AI applied to COVID-19 seems to be played by diagnostic imaging. However, AI in laboratory medicine is also gaining momentum, especially with digital tools characterized by low cost and widespread applicability.

Keyphrases

artificial intelligence
low cost
coronavirus disease
sars cov
machine learning
big data
deep learning
high resolution